Page 2 - AICOG

2
Welcome to AICOG 2023, Kolkata
Dr. Hrishikesh D Pai
President, FOGSI
I extend a warm welcome to all the
distinguished delegates to AICOG Kolkata,
the 65th All India Congress of Obstetrics
and Gynecology organized by The Bengal
Obstetric and Gynaecological Society in
Kolkata. The scientific program of AICOG
2023 is par excellence and will provide
an opportunity for new learning and
networking. I wish every FOGSI member
a bright future, healthy life, and success
in all their endeavors. But we should also
remember that our very purpose of living
and our every success should benefit our
society and make life meaningful to live for
us, for our brethren and everyone in our
country and the planet. Jai Hind !
Long Live FOGSI
Dr. Bhaskar Pal
Organizing Chairperson
On behalf of the organizing committee
of 65th All India Congress of Obstetrics
and Gynecology (AICOG 2023), I extend
a hearty welcome to all of you to the
City of Joy. I am indeed grateful for your
attendance during these uncertain times
where we are greatly confused if the
COVID pandemic is over or not. On our
part, we have tried our best to create a
carnival like atmosphere in this magnificent
venue where apart from science, you can
relax, make new friends, meet old friends,
do some shopping, enjoy the food and have
a good & enriching time together. I hope
and expect you all to return with lifelong
memories and updated knowledge from this
65th AlCOG. Jai Hind ! Long Live FOGSI
Consequences of Silent FMH on Rh(-ve) &
Latest FOGSI Guideline
As a result, fetal blood cells move away
from the higher-pressure fetal circulation
into the lower-pressure intervillous space
and ultimately into the maternal circulation.
Besides the consequences on the current
pregnancy, another important consequence
of FMH is Rh (D) isoimmunization in
Rh (D) negative patients, leading to
sensitization of the mother for future Rh(D)
+ve fetus. The assessment for FMH is also
Suspected FMH?
Initiate prompt testing must be administered to Rh-negative
Maternal RhD status: Maternal RhD status:
D‐negative D‐positive or D‐antigen alloimmunization. Most FMH cases
variant
ICT screening Kleihauer‐Betke test or anti‐
HbF flow cytometry
ICT positive ICT negative
Isoimmunized KB test Or prophylactic states that a single-dose regimen of 300 mcg
refer to fetal medicine
dose of AntiD
Figure 2. Assessment of Suspected FMH
Dr. Madhuri Patel
Secretar y General, FOGSI
It is my privilege to welcome you to
this august gathering of AICOG 2023.
The AICOGs are huge platforms for the
dissemination of knowledge, networking,
innovations, and collaboration. This is the
best time to focus your attention on the
recent outstanding achievements in the
field of obstetrics and gynecology. I am sure contribute to the learning process for
AICOG 2023 will offer you top-level quality
research and knowledge. So friends, let’s
live up to their expectations and participate the necessity for the implementation of
wholeheartedly in this grand gathering. My
best wishes for a fruitful AICOG 2023 and a
heartfelt thanks to the organizers for their
persistent efforts and hard work.
Dr. Dibyendu Banerjee
Organizing Secretar y
It is a truly humbling yet momentous
occasion for me along with the entire
organizing committee of the 65th All India
Congress of Obstetric and Gynecology to
extend a warm welcome to all of you to this
sprawling new venue, Biswa Bangla Mela
Prangan, in the city of joy Kolkota. We are
indeed thankful to FOGSI for providing
Bengal Obstetric & Gynaecological Society
the grand opportunity to organise this
prestigious congress after 15 long years.
We sincerely hope to make this conference
academically enriching, culturally fulfilling stay and leave with enduring memories of
and gastronomically satiating to each one of
you. Jai Hind ! Long Live FOGSI
Continued from page 1
based on the maternal Rh (D) status
(Figure 2).
The management of FMH includes
strict fetal surveillance and either fetal
intravascular transfusion (intrauterine)
or delivery with neonatal backup.
Corticosteroids for lung maturity and
magnesium sulfate for fetal neuroprotection
may be required for preterm gestation.
In addition, Rh (D) immune globulin
women within 72 hours after any
potentially sensitizing event to prevent
(of volume <10 mL) can be neutralized
by the low prophylactic dose of anti-D
immunoglobulin. A higher dose of
prophylaxis is needed in cases of severe
FMH (>30 mL) for neutralization. The
FOGSI Recommendation for Routine
Antenatal Anti-D Prophylaxis (RAADP)
IM in the deltoid is effective, economical,
and offers better compliance.
Dr. S Shantha Kumari
Immediate Past President, FOGSI
I am pleased to welcome you to AICOG
2023, Kolkata. The well-planned academic
sessions will enhance the technical skills
and development of obstetricians and
gynaecologists to face future challenges.
The exchange of ideas with renowned
faculty from all over the world will
everyone and will definitely have an impact
on improving clinical practice along with
technology and innovations. I congratulate
the organizing team for their hard work and
excellent planning of the scientific program. many thanks to all organizers.
Dr. Basab Mukherjee
Organizing Secretar y
Let me take this opportunity along with
our conference Chair to welcome 9000+
delegates and accompanying persons
who have registered for this conference.
The team of Bengal Obstetric and
Gynaecological society shall leave no stone
unturned towards offering you a pleasant
and enjoyable stay in Kolkata. The scientific entire organizing committee for tirelessly
team has done a commendable work for
stitching together a program including
practical and clinically relevant topics. We
sincerely hope that you will have a pleasant
your time with us during this 65th All India
Congress of Obstetric and Gynecology.
Jai Hind ! Long Live FOGSI
Dydrogesterone – A Preferred
Choice of Luteal Support in IVF
Controlled ovarian stimulation techniques
that are routinely used during IVF mandate
the use of exogenous follicle-stimulating
and gonadotrophin-releasing hormones.
However, controlled ovarian stimulation
often causes endocrine defects in the luteal
phase, which may jeopardize embryo
implantation and maintenance of early
pregnancy.
Therefore, luteal phase support is
necessary to support embryo implantation
and to enhance the probability of an
ongoing pregnancy. Hence, it is now
considered a standard practice to
support the luteal phase with exogenous
progestogens to improve pregnancy rates
obtained from IVF. Using progesterone
for luteal phase support is associated
with an improvement in pregnancy rates
in IVF treatment. Moreover, the chance
of developing ovarian hyperstimulation
syndrome with progesterone is 20 times
lower than that with hCG.
Oral, vaginal, and parenteral routes of
administration are the three available
routes for progesterone support in the
Dr. Jaydeep Tank
President Elect, FOGSI
My greetings to all the learned obstetricians
and gynaecologists attending this signature
event, AICOG 2023, the 65th All India
Congress of Obstetric & Gynecology
organized by The Bengal Obstetric and
Gynaecological Society, in Kolkata. Building
on the success of previous AICOGs, the
theme for 2023 is Creating Tomorrow
Together. I look forward to the excellent
discussions, that are the hallmark of the
AICOGs, surrounding the latest science on
the most pressing topics of our times. My
best wishes for a successful conference and
Dr. Abinash Chandra Ray
President, BOGS
At the outset let me welcome all of you
on behalf of the Bengal Obstetric and
Gynaecological Society to our beloved city
Kolkota. AICOG is the annual knowledge
festival, and it is a great opportunity to
learn from a large number of national
and international experts. Hats off to the
working day and night towards making this
a very successful meetingwhich is full of
academics and socio-cultural events. I hope
and expect that all of you will return with
lifelong memories and updated knowledge
from this 65th All India Congress of
Obstetrics and Gynecology. Wish you all a
Happy and Prosperous New Year.
luteal phase. Among these, many patients
may consider the vaginal and parenteral
routes inconvenient. In contrast, the oral
route of administration helps avoid the
inconvenience and side effects related
to intravaginal or intramuscular routes.
Dydrogesterone and natural micronized
progesterone are the two main oral
progestogens used in the setting of IVF.
Dydrogesterone, a retroprogesterone, has
been used since the 1960s in conditions of
progesterone deficiency. The bioavailability
of oral dydrogesterone is higher than that of
oral micronized progesterone. In addition,
it is a more selective progesterone receptor
agonist than progesterone and has a lower
affinity for androgen and glucocorticoid
receptors. The higher selectivity of
dydrogesterone for progesterone receptors
translates into endometrial transformation
at relatively lower doses and minimal
androgenic, estrogenic, anabolic, and
corticoid side effects.
A wealth of clinical evidence supports
the use of dydrogesterone in IVF. Several
Continued in Page 4